A NEW HOPE FOR OUR PATIENT SUFFERERS!
Mixed Anabolic Steroid Therapy with physician monitoring costs between $5000-7000.
Human growth hormone may be included in treatment as a separate $5000 cost.
The Novel Mixed Anabolic Therapy Program is expected to be effective in more than half of young adult mean and women. Based on our published peer-reviewed journal articles, international lectures, and previous success by other clinicians reports with anabolic steroids in IBD. The program is offered as a non-emergency surgery alternative after Humira®/ biologics and/or surgical failures. This specifically deals with the correlation of biomarker testing.
"Curing the world, one patient at a time!"
A NEW HOPE FOR OUR PATIENT SUFFERERS!
Do we have your attention?
Inflammatory Bowel Disease is a recent epigenetic maelstrom affecting 1.6 million of our young men and women in the United States. Increasingly discovered in the youngest of the population, presently 20% of Crohn's Disease sufferers will have surgery annually and 75 percent of those with ulcerative colitis will have their colons removed. Pain, suffering, early death and four times increased incidence of colon cancer makes Inflammatory Bowel Disease an unacceptable enigma. The last major group of medications for treating these patients are called the biologics and were approved 17-years ago.
The discovery of the Testosterone -- Estrogen Receptor-beta -- Cytokine Humoral Signaling is not just limited to gastroenterology disease. Two major gynecology university programs in the United States have already secured Institutional Review Board permission to send the serum T-lymphocytes to the international cell culture facility to perform matching studies on patients with endometriosis. The same three-part protocol is in progress: Part I untreated, Part II medication failure and Part III surgical failure. Lichten has already published an 8-year follow up on a case of Stage IV deep endometriosis involving the colon taken away from Johns Hopkins surgery. Of major scientific interest is that these gynecologic diseases of endometriosis, endometrial hyperplasia, endometrial, ovarian cancer and breast cancer are often associated with 100-fold increases in the estrogen receptor beta.
